NVRO Nevro Corp

Nevro Corp develops and sells medical devices mainly in the United States. Its main product is the Senza system which is intended to relieve leg and spinal cord pain with the application of the HF10 therapy.

$45.59  +1.76 (4.02%)
As of 07/01/2022 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  11/06/2014
Outstanding shares:  35,260,684
Average volume:  403,753
Market cap:   $1,545,475,780
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BS7K7C9
Valuation   (See tab for details)
PE ratio:   -11.81
PB ratio:   6.68
PS ratio:   4.00
Return on equity:   -56.63%
Net income %:   -35.25%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy